Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States

Samuel B Graitcer1, Larisa Gubareva, Laurie Kamimoto

  • 1Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

Insights

Oseltamivir-resistant pandemic (H1N1) 2009 virus was found in 0.5% of cases. Most resistant infections occurred in immunocompromised patients previously treated with oseltamivir, with no evidence of community spread.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Influenza A (H1N1)pdm09 virus emerged in 2009.
  • Oseltamivir is a key antiviral medication for influenza treatment.
  • Antiviral resistance is a growing public health concern.

Purpose of the Study:

  • To determine the prevalence of oseltamivir resistance in pandemic (H1N1) 2009 viruses.
  • To identify risk factors associated with oseltamivir-resistant infections.

Main Methods:

  • Analysis of pandemic (H1N1) 2009 viruses submitted to a US surveillance system between April 2009 and June 2010.
  • Phenotypic or genotypic testing for oseltamivir resistance.
  • Review of patient clinical data, including immunocompromised status and oseltamivir treatment history.

Main Results:

  • Thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses exhibited oseltamivir resistance.
  • The majority of patients (76%) with resistant infections were severely immunocompromised.
  • Most patients with resistant infections (89%) had received oseltamivir prior to specimen collection.

Conclusions:

  • Oseltamivir resistance in pandemic (H1N1) 2009 viruses was low during the study period.
  • Severely immunocompromised individuals with prior oseltamivir exposure are at higher risk for resistant infections.
  • No evidence of widespread community circulation of oseltamivir-resistant pandemic (H1N1) 2009 viruses was observed.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...